MiRNA-199a-5p regulates VEGFA in endometrial mesenchymal stem cells and contributes to the pathogenesis of endometriosis

Journal of Pathology

Volumn 232, Issue 3, 2014, Pages 330-343

  Hsu, Chia Yi ^a   Hsieh, Tsung Hua ^b   Tsai, Cheng Fang ^a   Tsai, Hung Pei ^a   Chen, Hung Sheng ^b   Chang, Yu ^b   Chuang, Hui Yu ^b   Lee, Jau Nan ^b   Hsu, Ya Ling ^a   Tsai, Eing Mei ^a,b,c  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

endometrial mesenchymal stem cells; endometriosis; miR 199a 5p; VEGFA

Indexed keywords

MICRORNA; MICRORNA 199A 5P; UNCLASSIFIED DRUG; VASCULOTROPIN A;

3' UNTRANSLATED REGION; ADULT; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MOTILITY; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; ENDOMETRIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION;

EID: 84892421364     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4295     Document Type: Article

References (73)

1. Giudice LC, Kao LC,. Endometriosis. Lancet 2004; 364: 1789-1799.
2. Bulun SE,. Endometriosis. N Engl J Med 2009; 360: 268-279.
3. Dinulescu DM, Ince TA, Quade BJ, et al., Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat Med 2005; 11: 63-70.
4. Sampson JA,. Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation. Am J Pathol 1927; 3: 93-110, 143.
5. Maruyama T, Yoshimura Y,. Stem cell theory for the pathogenesis of endometriosis. Front Biosci 2012; 4: 2854-2863.
6. Gargett CE,. Stem cells in gynaecology. Austr NZ J Obstet Gynaecol 2004; 44: 380-386.
7. Figueira PG, Abrao MS, Krikun G, et al., Stem cells in endometrium and their role in the pathogenesis of endometriosis. Ann NY Acad Sci 2011; 1221: 10-17.
8. Gotte M, Wolf M, Staebler A, et al., Increased expression of the adult stem cell marker Musashi-1 in endometriosis and endometrial carcinoma. J Pathol 2008; 215: 317-329.
9. Sasson IE, Taylor HS,. Stem cells and the pathogenesis of endometriosis. Ann NY Acad Sci 2008; 1127: 106-115.
10. Kao AP, Wang KH, Chang CC, et al., Comparative study of human eutopic and ectopic endometrial mesenchymal stem cells and the development of an in vivo endometriotic invasion model. Fertil Steril 2011; 95: 1308-1315, e1301.
11. Kao AP, Wang KH, Long CY, et al., Interleukin-1β induces cyclooxygenase-2 expression and promotes the invasive ability of human mesenchymal stem cells derived from ovarian endometrioma. Fertil Steril 2011; 96: 678-684, e671.
12. Balasch J, Creus M, Fabregues F, et al., Visible and non-visible endometriosis at laparoscopy in fertile and infertile women and in patients with chronic pelvic pain: a prospective study. Hum Reprod 1996; 11: 387-391.
13. Baldi A, Campioni M, Signorile PG,. Endometriosis: pathogenesis, diagnosis, therapy and association with cancer [review]. Oncol Rep 2008; 19: 843-846.
14. Guo SW,. Epigenetics of endometriosis. Mol Hum Reprod 2009; 15: 587-607.
15. Juo SH, Wu R, Lin CS, et al., A functional promoter polymorphism in interleukin-10 gene influences susceptibility to endometriosis. Fertil Steril 2009; 92: 1228-1233.
16. Anger DL, Foster WG,. The link between environmental toxicant exposure and endometriosis. Front Biosci 2008; 13: 1578-1593.
17. Kim SH, Chun S, Jang JY, et al., Increased plasma levels of phthalate esters in women with advanced-stage endometriosis: a prospective case-control study. Fertil Steril 2011; 95: 357-359.
18. Taylor RN, Lebovic DI, Mueller MD,. Angiogenic factors in endometriosis. Ann NY Acad Sci 2002; 955: 89-100; discussion, 118, 396-406.
19. Groothuis PG, Nap AW, Winterhager E, et al., Vascular development in endometriosis. Angiogenesis 2005; 8: 147-156.
20. Taylor RN, Yu J, Torres PB, et al., Mechanistic and therapeutic implications of angiogenesis in endometriosis. Reprod Sci 2009; 16: 140-146.
21. Ohlsson Teague EM, Van der Hoek KH, Van der Hoek MB, et al., MicroRNA-regulated pathways associated with endometriosis. Mol Endocrinol 2009; 23: 265-275.
22. Teague EM, Print CG, Hull ML,. The role of microRNAs in endometriosis and associated reproductive conditions. Hum Reprod Update 2010; 16: 142-165.
23. Hawkins SM, Creighton CJ, Han DY, et al., Functional microRNA involved in endometriosis. Mol Endocrinol 2011; 25: 821-832.
24. Pan Q, Luo X, Toloubeydokhti T, et al., The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression. Mol Hum Reprod 2007; 13: 797-806.
25. Bartel DP,. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-233.
26. Ambros V., The functions of animal microRNAs. Nature 2004; 431: 350-355.
27. Chen X, Ba Y, Ma L, et al., Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18: 997-1006.
28. Mitchell PS, Parkin RK, Kroh EM, et al., Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105: 10513-10518.
29. Lin SC, Wang CC, Wu MH, et al., Hypoxia-induced microRNA-20a expression increases ERK phosphorylation and angiogenic gene expression in endometriotic stromal cells. J Clin Endocrinol Metab 2012; 97: E1515-1523.
30. Somigliana E, Vigano P, Rossi G, et al., Endometrial ability to implant in ectopic sites can be prevented by interleukin-12 in a murine model of endometriosis. Hum Reprod 1999; 14: 2944-2950.
31. Chuang PC, Lin YJ, Wu MH, et al., Inhibition of CD36-dependent phagocytosis by prostaglandin E2 contributes to the development of endometriosis. Am J Pathol 2010; 176: 850-860.
32. Lewis BP, Burge CB, Bartel DP,. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20.
33. Donnez J, Smoes P, Gillerot S, et al., Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod 1998; 13: 1686-1690.
34. Takehara M, Ueda M, Yamashita Y, et al., Vascular endothelial growth factor A and C gene expression in endometriosis. Hum Pathol 2004; 35: 1369-1375.
35. Farre D, Roset R, Huerta M, et al., Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucleic Acids Res 2003; 31: 3651-3653.
36. Schwarte-Waldhoff I, Volpert OV, Bouck NP, et al., Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis. Proc Natl Acad Sci USA 2000; 97: 9624-9629.
37. Ishibashi O, Ohkuchi A, Ali MM, et al., Hydroxysteroid (17β) dehydrogenase 1 is dysregulated by miR-210 and miR-518c that are aberrantly expressed in pre-eclamptic placentas: a novel marker for predicting preeclampsia. Hypertension 2012; 59: 265-273.
38. Yin G, Chen R, Alvero AB, et al., TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214. Oncogene 2010; 29: 3545-3553.
39. Chao A, Lin CY, Lee YS, et al., Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2. Oncogene 2012; 31: 764-775.
40. Georgieva B, Milev I, Minkov I, et al., Characterization of the uterine leiomyoma microRNAome by deep sequencing. Genomics 2012; 99: 275-281.
41. Wang WT, Zhao YN, Han BW, et al., Circulating microRNAs identified in genome-wide serum microRNA expression analysis as noninvasive biomarkers for endometriosis. J Clin Endocrinol Metab 2013; 98: 281-289.
42. Filigheddu N, Gregnanin I, Porporato PE, et al., Differential expression of microRNAs between eutopic and ectopic endometrium in ovarian endometriosis. J Biomed Biotechnol 2010; 2010: 369549.
43. Li Y, Xie J, Xu X, et al., MicroRNA-548 down-regulates host antiviral response via direct targeting of IFN-λ1. Protein Cell 2012; 4: 130-141.
44. Rossato M, Curtale G, Tamassia N, et al., IL-10-induced microRNA-187 negatively regulates TNFα, IL-6, and IL-12p40 production in TLR4-stimulated monocytes. Proc Natl Acad Sci USA 2012; 109: E3101-3110.
45. Cheng Z, Qiu S, Jiang L, et al., MiR-320a is downregulated in patients with myasthenia gravis and modulates inflammatory cytokines production by targeting mitogen-activated protein kinase. J Clin Immunol 2012; 33: 567-576.
46. Lai L, Song Y, Liu Y, et al., MicroRNA-92a negatively regulates TLR-triggered inflammatory response in macrophages by targeting MKK4. J Biol Chem 2013; 288: 7956-7967.
47. Trenkmann M, Brock M, Gay RE, et al., The TNFα-induced miR-18a activates rheumatoid arthritis synovial fibroblasts through a feedback loop in NF-κB signaling. Arthritis Rheumat 2012; 65: 916-927.
48. Boeri M, Verri C, Conte D, et al., MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci USA 2011; 108: 3713-3718.
49. Luo Z, Dai Y, Zhang L, et al., miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma. Carcinogenesis 2012; 34: 415-425.
50. Guidi M, Muinos-Gimeno M, Kagerbauer B, et al., Overexpression of miR-128 specifically inhibits the truncated isoform of NTRK3 and upregulates BCL2 in SH-SY5Y neuroblastoma cells. BMC Mol Biol 2010; 11: 95.
51. 1/S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma. Carcinogenesis 2011; 32: 1641-1647.
52. Duan H, Jiang Y, Zhang H, et al., MiR-320 and miR-494 affect cell cycles of primary murine bronchial epithelial cells exposed to benzo[a]pyrene. Toxicol In Vitro 2010; 24: 928-935.
53. Nigro A, Menon R, Bergamaschi A, et al., MiR-30e and miR-181d control radial glia cell proliferation via HtrA1 modulation. Cell Death Dis 2012; 3: e360.
54. de Faria O, Jr., Cui QL, Bin JM, et al. Regulation of miRNA 219 and miRNA clusters 338 and 17-92 in oligodendrocytes. Front Genet 2012; 3: 46.
55. Zhang Z, Kang Y, Zhang Z, et al., Expression of microRNAs during chondrogenesis of human adipose-derived stem cells. Osteoarthr Cartilage 2012; 20: 1638-1646.
56. Incoronato M, Garofalo M, Urso L, et al., miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED. Cancer Res 2010; 70: 3638-3646.
57. Niu H, Wang K, Zhang A, et al., miR-92a is a critical regulator of the apoptosis pathway in glioblastoma with inverse expression of BCL2L11. Oncol Rep 2012; 28: 1771-1777.
58. Ren XP, Wu J, Wang X, et al., MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation 2009; 119: 2357-2366.
59. Shen Q, Cicinnati VR, Zhang X, et al., Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion. Mol Cancer 2010; 9: 227.
60. Peng RQ, Wan HY, Li HF, et al., MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl-α- d -galactosamine:polypeptide N-acetylgalactosaminyltransferase 7. J Biol Chem 2012; 287: 14301-14309.
61. Zhou T, Zhang G, Liu Z, et al., Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer. Int J Colorect Dis 2013; 28: 19-24.
62. Takei Y, Takigahira M, Mihara K, et al., The metastasis-associated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancer. Cancer Res 2011; 71: 1442-1453.
63. Song J, Kim D, Jin EJ,. MicroRNA-488 suppresses cell migration through modulation of the focal adhesion activity during chondrogenic differentiation of chick limb mesenchymal cells. Cell Biol Int 2011; 35: 179-185.
64. Bonauer A, Carmona G, Iwasaki M, et al., MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009; 324: 1710-1713.
65. Vickers KC, Remaley AT,. Lipid-based carriers of microRNAs and intercellular communication. Curr Opin Lipidol 2012; 23: 91-97.
66. Arroyo JD, Chevillet JR, Kroh EM, et al., Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 2011; 108: 5003-5008.
67. Dai L, Gu L, Di W,. MiR-199a attenuates endometrial stromal cell invasiveness through suppression of the IKKβ/NF-κB pathway and reduced interleukin-8 expression. Mol Hum Reprod 2012; 18: 136-145.
68. Cheung HH, Davis AJ, Lee TL, et al., Methylation of an intronic region regulates miR-199a in testicular tumor malignancy. Oncogene 2011; 30: 3404-3415.
69. Ramon LA, Braza-Boils A, Gilabert-Estelles J, et al., microRNAs expression in endometriosis and their relation to angiogenic factors. Hum Reprod 2011; 26: 1082-1090.
70. Rane S, He M, Sayed D, et al., Downregulation of miR-199a derepresses hypoxia-inducible factor-1α and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res 2009; 104: 879-886.
71. Critchley HO, Osei J, Henderson TA, et al., Hypoxia-inducible factor-1α expression in human endometrium and its regulation by prostaglandin E-series prostanoid receptor 2 (EP2). Endocrinology 2006; 147: 744-753.
72. Hahn SA, Schutte M, Hoque AT, et al., DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996; 271: 350-353.
73. Mabuchi Y, Yamoto M, Minami S, et al., Immunohistochemical localization of inhibin and activin subunits, activin receptors and Smads in ovarian endometriosis. Int J Mol Med 2010; 25: 17-23.